Apollo unveils India’s first fully integrated gynae-oncology and robotic surgery ecosystem for women

Apollo Athenaa, Asia’s first comprehensive cancer centre dedicated exclusively to women, has announced the launch of India’s first fully integrated Gynae-Oncology and Robotic Surgery ecosystem, designed to address one of the most critical and underserved gaps in cancer care for women.

Gynaecological cancers continue to pose a significant and growing burden in India. According to GLOBOCAN 2022, gynaecological cancers rank among the leading cancers affecting Indian women, contributing substantially to cancer-related morbidity and mortality. Complementing this, 2025 data from the Indian Council of Medical Research shows over 1,71,000 new cases of female genital cancers and nearly 86,000 deaths in a year pointing to a significant mortality burden.

Despite this high disease burden, access to specialised, integrated care remains limited, treatment pathways are often fragmented across multiple providers, and early-stage specialist intervention continues to be out of reach for a large proportion of patients.

In response to this growing crisis, Apollo Athenaa’s newly launched Gynae-Oncology and Robotic Surgery facility is designed to bridge the critical gap between rising case volumes and access to specialised, integrated care. By bringing together early detection, precision diagnostics, advanced robotic and minimally invasive surgery, and comprehensive post-treatment support within a single, coordinated framework, the ecosystem eliminates the need for patients to navigate fragmented care pathways across multiple providers.

At its core, the model enables timely specialist intervention which is one of the most crucial factors in improving outcomes in gynaecological cancers, while also expanding access to fertility-preserving treatments, high end surgical intervention, shorter hospital stay, accelerated recovery and ability to resume their normal lifestyle and pathways.

By embedding multidisciplinary expertise into every stage of the patient journey, Apollo Athenaa is not only addressing the shortage of integrated, gender-specific cancer centres in India but also setting a new benchmark for how women’s cancers are treated, holistically, precisely, and with continuity of care.